Cite

HARVARD Citation

    Taiwo, B. et al. (n.d.). 877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes. Open forum infectious diseases. pp. S530-S531. [Online]. 
  
Back to record